TruScreen Group Limited

Company Profile

Sector

Healthcare

Industry

Medical Devices

Employees

N/A

Website

www.truscreen.com

Country

New Zealand

Exchange

ASX

Auckland, New Zealand

TruScreen develops, manufacture, and sale of cancer detection devices and systems in Mexico, China, Russia, Vietnam, Zimbabwe, and the Middle East/North Africa. It offers the TruScreen cervical cancer screening device, a medical device for identifying and detecting the presence of precancerous and cancerous tissue on the cervix in real time. Incorporated in 2013 and headquartered in Auckland, New Zealand, TruScreen was formerly known as TruScreen Limited before rebranding in August 2020.

Key Stats

52-Week Range

A$0.01A$0.03

Beta-0.05

Trailing P/EN/A

Forward P/EN/A

Trailing EPS0.00

Avg Volume

Earnings & Analyst

Next EarningsN/A

EPS EstimateN/A

Target Mean PriceA$0.02

RecommendationNone

Recommendation MeanN/A

Recent SEC Filings

SEC filings for this ticker are not available yet.